Hospitals, Facilities and Providers

Themenbereich / / Hospitals, Facilities and Providers

Sortiere PresseMitteilungen nach: Titel (A\D) Datum (A\D)

Seiten sind aktuell sortiert nach: Datum (erst neue PresseMitteilungen)

H-Source Announces Agreement With the Premier U.S. Supply Chain Membership Group

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/25/17 -- H-Source Holdings Ltd. (TSX VENTURE: HSI)(OTCQB: HSCHF) (the "Company" or "H-Source") is pleased to announce that it has entered into an Advertising and Sponsorship Agreement with Association for Healthcare Resource & Materials Management ("AHRMM"). The AHRMM is the premier membership group for healthcare supply chain professionals. AHRMM strives to provide the education, information, and resources necessary for its members to remain at the top of their field. With more than 4,500 members worldwide, ...


DiaMedica Announces Dr. Nancy Chang to its Strategic Advisory Board

MINNEAPOLIS, MINNESOTA -- (Marketwired) -- 04/25/17 -- DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE: DMA)(OTCQB: DMCAF) is pleased to announce the addition of Dr. Nancy Chang to its Strategic Advisory Board to support the Company''s development of its lead product, DM199. Dr. Chang brings more than 30 years of experience in the biopharmaceutical industry, successfully developing and commercializing therapeutic and diagnostic products. She is the co-founder of Tanox, Inc., a biotechnology company known for the development of Xolaira, the breakthrough drug which ...


Desert Oasis Healthcare Establishes Center for Research and Healthcare Innovation Featuring Altura''s HCP Studies(TM) Mobile Platform

MISSION VIEJO, CA and PALM SPRINGS, CA -- (Marketwired) -- 04/19/17 -- Desert Oasis Healthcare (DOHC), a California-based Physician Group within the Heritage Provider Network, today announced the establishment of a Center for Research and Healthcare Innovation (DCRI). Created in collaboration with partner Altura, the DCRI is designed to build upon the long-standing clinical trial resources at DOHC. By implementing Altura''s Study Engagement Platform™, DCRI will expand DOHC''s capabilities to support observational studies, healthcare technology assessments, and patient and ...


DiaMedica Therapeutics Completes Private Placement With U.S. Based Family Office

MINNEAPOLIS, MINNESOTA -- (Marketwired) -- 04/18/17 -- DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE: DMA)(OTCQB: DMCAF), a biopharmaceutical company focused on the development of DM199 (recombinant human KLK1), is pleased to announce it has completed a non-brokered private placement with a prominent U.S. investor (the "Offering") with the issuance of 10,526,315 units (the "Units") at an issue price of USD$0.19 (CAD$0.25) per Unit for gross proceeds of approximately USD$2,000,000. The proceeds will be used by the Company to advance its research and dev ...


Global Hybrid Operating Rooms Sales Market to Witness an impressive CAGR by the End of 2022

Albany, New York, April 13, 2017: The development of the hybrid operating rooms has been successful due to the combined effects of both minimally invasive procedures and imaging technologies. The hybrid operating room makes it possible to simultaneously reach a diagnosis and provide treatment during surgical interventions, therefore gaining huge momentum all over the world. Market Research Hub (MRH) has recently updated its massive catalog by adding a new study, titled as “Global Hybrid Operating Rooms Sales Market” Report 2017. This study analyzes the global market and throws lights on the fu ...


New Study Published in The American Journal of Medicine Expands the Clinical Evidence Underscoring the Value of the Corus(R) CAD Blood Test to Help Safely Direct Cardiovascular Care

REDWOOD CITY, CA -- (Marketwired) -- 04/12/17 -- , a molecular diagnostics company specializing in , announced today the publication of results from the multi-center, community-based PRESET Registry in the peer-reviewed journal, The American Journal of Medicine.(1) The study results provided further confirmation of the clinical utility of the to help clinicians in real-world practice determine if their patients'' symptoms are due to a blockage in the heart arteries, and if referral to cardiology or to advanced cardiac testing was necessary. Previously validated with a 96% negative ...


Just Associates Experts to Discuss Patient Matching Challenges in California Health Information Association Webinar

CENTENNIAL, CO -- (Marketwired) -- 04/11/17 -- , a nationally recognized leader in patient matching and health information data integrity and management, announced today that two of its experts will discuss Master Patient Index (MPI) data integrity issues and preventive solutions during a California Health Information Association (CHIA) webinar on "Why Patient Matching Is a Challenge: Research on MPI Data Discrepancies in Key Identifying Fields."With an extensive background in health information management (HIM), Just Associates CEO and President Beth Just, MBA, RHIA, FAHIMA, a nati ...


ConcertoHealth(R) Names Kellie J. Rice Executive Director for Michigan Market

IRVINE, CA -- (Marketwired) -- 04/10/17 -- , the leading provider of specialized primary care and supporting clinical services for complex, frail, elderly and dual-eligible patients, has appointed Kellie J. Rice as executive director for its Michigan market, effective April 3, 2017.Rice will oversee ConcertoHealth''s population health management services for its health plan partners in Michigan, and will work directly with community providers and facilities from the company''s Detroit, Mich. administrative office."Kellie''s experience in health plan and netw ...


Prolacta Bioscience(R) Names New Nutrition Advisory Committee Members and Expands Resources for NICU Dietitians and Clinicians

DUARTE, CA -- (Marketwired) -- 03/30/17 -- , the pioneer in human milk-based neonatal nutritional products for premature infants, today announced two new members of its Nutrition Advisory Committee (NAC): Keli Hawthorne, MS, RD, LD of Austin, Texas, and Carrie L. Petras, RD of Louisville, Ky.The NAC includes registered dietitians and board-certified specialists in pediatric nutrition, breast feeding medicine and human milk nutrition. Their goal is to provide neonatal intensive care units (NICUs) with clinical expertise, research, insights and guidance on the feeding and nutrition of extremely ...


BC Paramedics launch new campaign to raise awareness around lacking resources

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/28/17 -- Today, the Ambulance Paramedics and Emergency Dispatchers of British Columbia CUPE Local 873 (APBC), launched a multi-platform, province-wide public awareness campaign designed to bring the public attention to the calls answered by BC''s Emergency Dispatchers every day.The campaign will bring the public up close and personal to BC''s most common public issues and medical emergencies, seen through the eyes of BC''s paramedics. It is intended to raise awareness around the essential services provided by BC ...


DiaMedica Announces Issuance of European Composition of Matter Patent and Additional Worldwide Filings for DM199

MINNEAPOLIS, MINNESOTA -- (Marketwired) -- 03/20/17 -- DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE: DMA)(OTCQB: DMCAF), today announced that the European Patent Office has issued European Patent No. 2854841, entitled "Human Tissue Kallikrein 1 Glycosylation Isoforms". This patent contains claims that cover the composition of matter of DiaMedica''s product candidate, DM199, and pharmaceutical compositions comprising DM199. The patent protects key composition of matter of DM199''s proprietary recombinant kallikrien protein. The patent has an ...


DiaMedica Issues Stock Option Grant

MINNEAPOLIS, MINNESOTA -- (Marketwired) -- 03/17/17 -- DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE: DMA)(OTCQB: DMCAF) today announces that the Board of Directors has granted options to purchase 300,000 common shares of the Corporation to the Company''s management at an exercise price of $0.25 per share. These options were awarded in accordance with the Company''s stock option plan for a ten-year term.About DiaMedica Therapeutics Inc.DiaMedica Therapeutics is a clinical stage biopharmaceutical company focused on developing novel treatments for neurol ...


Automated Harm Trigger System Enables Real-Time Identification of Patients at Risk

OAKBROOK TERRACE, IL -- (Marketwired) -- 03/16/17 -- An Office of Inspector General report in 2010 recommended internal hospital reporting of all harms -- whether considered a complication, a preventable harm, or a harm caused by system failures or errors (all-cause harm). A study in the April 2017 issue of details how the Adventist Health System Patient Safety Organization, Altamonte Springs, Florida, developed an automated all-cause harm trigger system to enable the identification of current patients who may have experienced harm or may be at risk for harm.The study, "Developing and E ...


DiaMedica Presents Updated Positive DM199 Phase Ib Trial Identifying A Superior Subcutaneous Delivery Profile

MINNEAPOLIS, MINNESOTA -- (Marketwired) -- 03/13/17 --DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE: DMA)(OTCQB: DMCAF), a clinical stage biopharmaceutical company developing synthetic protein treatments for neurological and kidney diseases, reports positive results from its Phase Ib bridging trial. The study was designed to compare the profile of DM199 to the approved urinary KLK1 product (trade name Kailikang®) on the market in Asia for acute ischemic stroke. The reference drug is administered intravenously and has a very short half-life. The DiaMedica study identified a ...


SHOM to Expand its Services and Technologies Into China and Asia via Medical Treasure

NEW YORK, NY -- (Marketwired) -- 03/07/17 -- Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer in the Healthcare industry, has announced that it will expand its services and technologies into China and Asia via cooperation of the ''Medical Treasure,'' which aims to improve the quality of life of both patients and doctors alike.The Medical Treasure can provide professional medical assistance and family care function. It guides patients to develop self-control, self-examination, and self-learning habits. It provides a complete program to help doctors guide pat ...


First Choice Healthcare Solutions Appoints Dr. Steve Ryland to Lead Major Expansion of Physical/Occupational Therapy Division

MELBOURNE, FL -- (Marketwired) -- 02/28/17 -- (OTCQB: FCHS) ("FCHS," "First Choice" or the "Company"), one of the nation''s only non-physician-owned, publicly traded healthcare services companies focused on the delivery of total musculoskeletal solutions with an emphasis on Orthopaedics and Spine care, today announced that Steve Ryland, PT, DPT has been appointed to serve as the Company''s Director of Physical/Occupational Therapy ("PT/OT").In this role, Dr. Ryland will oversee the PT/OT Division and implement key expansion initiati ...


Arch Therapeutics Provides Corporate Milestone Update, Including Anticipated Filing of 510(k) for AC5(TM)

FRAMINGHAM, MA -- (Marketwired) -- 02/16/17 -- Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB: ARTH), developer of innovative materials as hemostatic and wound care devices, provided a corporate update during a live webcast this morning at 10:45 a.m. ET at the RHK Capital 2017 Disruptive Growth & Healthcare Conference in New York City. Replays of the live webcast can be accessed here: . The presentation slides are available for download at: .During the presentation, Dr. Norchi announced that the 510(k) filing for external use of AC5™ will be further advanced to mid-2017 from t ...


Prolacta Bioscience(R) Initiates Clinical Trial to Evaluate the Effect of a Specially Fortified Exclusive Human Milk Diet to Improve Growth in Infants Born with Single Ventricle Congenital Heart Defect

DUARTE, CA -- (Marketwired) -- 02/16/17 -- Prolacta Bioscience®, the pioneer in human milk-based neonatal nutritional products, announced today that the first patient has been enrolled in a clinical study to evaluate the effect of a specially fortified exclusive human milk diet (EHMD)(1) to improve growth in infants who have undergone surgery for a serious heart defect known as single ventricle cardiac physiology. Prolacta developed a first-of-its-kind, human milk-based fortifier to address the post-surgical nutrition needs of this fragile infant population.Single ventricle cardiac physiology ...


UPDATE - Solera Health Achieves HITRUST CSF Certification through the Health Information Trust Alliance (HITRUST)

PHOENIX, AZ -- (Marketwired) -- 02/09/17 -- , an integrator of chronic disease prevention and management solutions, announced today that it has earned certified status from the Health Information Trust Alliance (HITRUST). The certification provides assurance to Solera''s health plan, employer and health system clients that Solera meets the healthcare industry''s highest standards in protecting healthcare information and managing risk."HITRUST is a high-level security framework that gives our clients confidence that our processes maintain the highest level of security ...


Orb Health Soars to 2017 Patient and Growth Milestones

PHOENIX, AZ -- (Marketwired) -- 02/07/17 -- Collaborative care technology leader today announced a number of new milestones that together demonstrate the opportunity for combined service and solutions providers in population health management.Over the last 45-days, Orb Health announced $3.2 million in total funding, added its 100,000th patient under management, and opened the doors on a newly expanded flagship operation in downtown Phoenix. The Company expects to double the number of patients on its collaborative care platform within the next month, and is already preparing a technology upda ...


Page 4 from 127:  « ..  3 4 5  6  .. » 127

All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 82

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.